• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童和青少年对非甾体抗炎药的过敏反应:交叉不耐受反应。

Hypersensitivity to Nonsteroidal Anti-inflammatory Drugs in Children and Adolescents: Cross-Intolerance Reactions.

出版信息

J Investig Allergol Clin Immunol. 2015;25(4):259-69.

PMID:26310040
Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are used worldwide and are responsible for several types of drug hypersensitivity reactions (DHRs) in all age groups. The 2 major groups of DHRs to NSAIDs are those induced by immunological mechanisms (selective reactions) and those where inflammatory mediators are released through activation of the prostaglandin-leukotriene pathway without specific immunological recognition (cross-intolerance). In the present review, we focus on cross-intolerance reactions, which are the most frequent DHRs and are becoming a topic of major interest in children and adolescents. Paracetamol and ibuprofen are the drugs that most frequently cause DHRs in children; other NSAIDs are responsible for reactions in adolescents. In vivo and in vitro tests are of limited diagnostic value, with some exceptions for the less common selective reactions. In cross-intolerance, the clinical history and controlled administration are in many instances the only way to establish a diagnosis and look for alternatives. The clinical history is diagnostic when consistent symptoms occur repeatedly after exposure to NSAIDs with different chemical structures. Cutaneous and respiratory symptoms often co-occur in young children. The natural history of these reactions in children is unknown, and some patients can develop tolerance over time. Atopy remains a major risk factor for cross-intolerant reactions. The increasing interest in hypersensitivity to NSAIDs with improvements in patient phenotyping and the information provided by pharmacogenetics will improve our understanding and management of these reactions in the near future.

摘要

非甾体抗炎药(NSAIDs)在全球范围内广泛使用,可导致所有年龄段人群发生多种类型的药物超敏反应(DHR)。DHR 可分为 2 大主要类型,一类是由免疫机制引起的(选择性反应),另一类是通过激活前列腺素-白三烯途径释放炎症介质而引起,没有特定的免疫识别(交叉不耐受)。本综述重点关注交叉不耐受反应,它是最常见的 DHR,在儿童和青少年中已成为一个主要研究课题。在儿童中,对乙酰氨基酚和布洛芬是最常引起 DHR 的药物;在青少年中,其他 NSAIDs 则会引起反应。体内和体外试验的诊断价值有限,对于较少见的选择性反应有一些例外。在交叉不耐受中,临床病史和控制用药在许多情况下是唯一能确诊和寻找替代药物的方法。如果在接触不同化学结构的 NSAIDs 后反复出现一致的症状,则临床病史具有诊断意义。在幼儿中,皮肤和呼吸道症状常同时出现。这些反应在儿童中的自然病程尚不清楚,有些患者可能随时间推移而产生耐受。特应性仍然是交叉不耐受反应的主要危险因素。随着对 NSAIDs 超敏反应的关注度增加,以及患者表型分析和药物遗传学提供的信息的改善,在不久的将来,我们将更好地理解和管理这些反应。

相似文献

1
Hypersensitivity to Nonsteroidal Anti-inflammatory Drugs in Children and Adolescents: Cross-Intolerance Reactions.儿童和青少年对非甾体抗炎药的过敏反应:交叉不耐受反应。
J Investig Allergol Clin Immunol. 2015;25(4):259-69.
2
Hypersensitivity Reactions to Nonsteroidal Anti-inflammatory Drugs in Children and Adolescents: Selective Reactions.儿童和青少年对非甾体抗炎药的超敏反应:选择性反应
J Investig Allergol Clin Immunol. 2015;25(6):385-95.
3
Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders.非甾体抗炎药诱导的皮肤疾病患者对乙酰氨基酚和尼美舒利不耐受的危险因素。
Ann Allergy Asthma Immunol. 1999 Jun;82(6):554-8. doi: 10.1016/S1081-1206(10)63166-3.
4
Acetyl Salicylic Acid Challenge in Children with Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs Differentiates Between Cross-Intolerant and Selective Responders.乙酰水杨酸激发试验在非甾体类抗炎药过敏反应患儿中鉴别交叉过敏和选择性反应者。
J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1226-1235. doi: 10.1016/j.jaip.2017.08.029. Epub 2017 Oct 3.
5
Immediate Reactions to More Than 1 NSAID Must Not Be Considered Cross-Hypersensitivity Unless Tolerance to ASA Is Verified.除非对阿司匹林的耐受性得到证实,否则对一种以上非甾体抗炎药的即刻反应不应被视为交叉过敏。
J Investig Allergol Clin Immunol. 2017;27(1):32-39. doi: 10.18176/jiaci.0080.
6
Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients.药物过敏反应:大型系列患者中的反应模式、涉及药物和时间变化。
J Investig Allergol Clin Immunol. 2012;22(5):363-71.
7
[Allergic and pseudoallergic reactions to analgesics, antipyretics and non-steroidal anti-inflammatory drugs].[镇痛药、退热药及非甾体抗炎药的过敏反应和类过敏反应]
Arch Pediatr. 2007 May;14(5):507-12. doi: 10.1016/j.arcped.2007.03.009. Epub 2007 Apr 17.
8
[Allergic and non-allergic hypersensitivity to non-opioid analgesics, antipyretics and nonsteroidal anti-inflammatory drugs in children: epidemiology, clinical aspects, pathophysiology, diagnosis and prevention].[儿童对非阿片类镇痛药、解热药和非甾体抗炎药的过敏及非过敏超敏反应:流行病学、临床特征、病理生理学、诊断与预防]
Arch Pediatr. 2012 May;19(5):556-60. doi: 10.1016/j.arcped.2012.01.018. Epub 2012 Feb 29.
9
Possible link between history of hypersensitivity to a specific non-steroidal anti-inflammatory drug (NSAID) and positive results following challenge test to alternative NSAIDS.对特定非甾体抗炎药(NSAID)过敏史与对替代NSAIDs激发试验阳性结果之间的可能联系。
Arzneimittelforschung. 2009;59(8):410-4. doi: 10.1055/s-0031-1296416.
10
Drug provocation tests in the diagnosis of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in children.药物激发试验在儿童非甾体类抗炎药过敏反应诊断中的应用。
Pediatr Allergy Immunol. 2013 Mar;24(2):151-9. doi: 10.1111/pai.12039.

引用本文的文献

1
Risk factors for drug hypersensitivity reactions in children.儿童药物过敏反应的危险因素。
Ital J Pediatr. 2024 Jul 15;50(1):127. doi: 10.1186/s13052-024-01694-x.
2
Diagnostic evaluation of hypersensitivity reactions to arylpropionic acid derivatives: a descriptive observational study focusing on clinical characteristics and potential risk factors in children.芳香基丙酸衍生物过敏反应的诊断评估:一项描述性观察研究,重点关注儿童的临床特征和潜在危险因素。
Int J Clin Pharm. 2024 Dec;46(6):1294-1306. doi: 10.1007/s11096-024-01756-4. Epub 2024 Jun 11.
3
NSAID Hypersensitivity in the Pediatric Population: Classification and Diagnostic Strategies.
儿科人群中的非甾体抗炎药超敏反应:分类与诊断策略
J Asthma Allergy. 2022 Sep 28;15:1383-1399. doi: 10.2147/JAA.S267005. eCollection 2022.
4
NSAID-induced reactions: classification, prevalence, impact, and management strategies.非甾体抗炎药引起的反应:分类、患病率、影响及管理策略。
J Asthma Allergy. 2019 Aug 8;12:217-233. doi: 10.2147/JAA.S164806. eCollection 2019.
5
Mechanisms of hypersensitivity reactions induced by drugs.药物引起的超敏反应机制。
Acta Biomed. 2019 Jan 28;90(3-S):44-51. doi: 10.23750/abm.v90i3-S.8160.
6
SIAIP position paper: provocation challenge to antibiotics and non-steroidal anti-inflammatory drugs in children.SIAIP 立场文件:儿童抗生素和非甾体抗炎药激发挑战。
Ital J Pediatr. 2018 Dec 7;44(1):147. doi: 10.1186/s13052-018-0589-3.
7
Probable cutaneous adverse drug reaction to piroxicam in a cat.猫对吡罗昔康可能的皮肤药物不良反应。
JFMS Open Rep. 2018 Jul 23;4(2):2055116918786598. doi: 10.1177/2055116918786598. eCollection 2018 Jul-Dec.
8
NSAID hypersensitivity - recommendations for diagnostic work up and patient management.非甾体抗炎药超敏反应——诊断检查及患者管理建议
Allergo J Int. 2018;27(4):114-121. doi: 10.1007/s40629-018-0064-0. Epub 2018 May 25.
9
Disparities in rate, triggers, and management in pediatric and adult cases of suspected drug-induced anaphylaxis in Canada.加拿大疑似药物诱发过敏反应的儿科和成人病例在发病率、诱因和管理方面的差异。
Immun Inflamm Dis. 2018 Mar;6(1):3-12. doi: 10.1002/iid3.201. Epub 2017 Nov 1.
10
Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.用于儿童和青少年慢性非癌性疼痛的非甾体抗炎药(NSAIDs)
Cochrane Database Syst Rev. 2017 Aug 2;8(8):CD012537. doi: 10.1002/14651858.CD012537.pub2.